Journal of Nuclear Medicine Technology December 2025, jnmt.125.270581; DOI: https://doi.org/10.2967/jnmt.125.270581 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.271145; DOI: https://doi.org/10.2967/jnmt.125.271145 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.270843; DOI: https://doi.org/10.2967/jnmt.125.270843 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.271143; DOI: https://doi.org/10.2967/jnmt.125.271143 ...
Journal of Nuclear Medicine Technology August 2025, jnmt.125.269873; DOI: https://doi.org/10.2967/jnmt.125.269873 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.270227; DOI: https://doi.org/10.2967/jnmt.125.270227 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
From the early use of radioiodine to the expanding reach of prostate-specific membrane antigen and somatostatin receptor ...
Theranostic programs are expanding rapidly, creating a growing need to understand how institutions implement ...
Radioligand therapy (RLT) is a recent term for long established nuclear medicine practices. Although radioiodine provides the historical foundations of theranostics, the prototype RLTs include ...
Amyloidosis refers to a collective group of rare diseases in which there are deposits of protein-based infiltrates within the extracellular tissue space (1). Proteins perform a wide range of essential ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback